ArticleScientific reports2019

Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis.

Apeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.